Levacetam 750mg Tablet contains Levetiracetam, an antiepileptic agent indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam’s exact mechanism of action is not fully understood; however, it is believed to modulate synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby inhibiting abnormal neuronal excitability. This medication is typically prescribed as adjunctive therapy in adults and pediatric patients aged four years and older. Levacetam 750mg Tablet is administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects may include somnolence, dizziness, headache, and fatigue, though it is generally well tolerated. Caution is advised in patients with renal impairment, necessitating dosage adjustments to prevent accumulation. It is contraindicated in individuals with known hypersensitivity to Levetiracetam or any tablet components. Patients should be monitored regularly for changes in mood or behavior, as neuropsychiatric symptoms have been reported. Levacetam does not induce hepatic enzymes, thus exhibiting minimal drug-drug interactions. This profile makes Levacetam 750mg Tablet a valuable option in managing various seizure types, improving seizure control and patient quality of life when used under appropriate medical supervision.